Tempest Therapeutics (TPST) Stock Surges Wednesday: What's Driving the Action?
Shares of Tempest Therapeutics Inc (NASDAQ: TPST) are trading sharply higher Wednesday morning as investors respond positively to a strategic agreement expanding the company's next-generation cell therapy pipeline.
Tempest made a deal to add more cell therapy treatments to its pipeline. When a company expands what it's working on, watch if they have the money and focus to finish those projects well.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.